Metropolitan Life Insurance CO Precigen, Inc. Transaction History

Metropolitan Life Insurance CO

$252 Million
Q4 2024

34 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$1.21 - $1.75 $2,009 - $2,906	1,661 Added 141.24%	2,837 $4,000
Q4 2023 Feb 14, 2024	SELL	$0.89 - $1.41 $5,011 - $7,939	-5,631 Reduced 82.72%	1,176 $1,000
Q1 2023 May 15, 2023	BUY	$0.88 - $2.19 $433 - $1,079	493 Added 7.81%	6,807 $7,000
Q4 2022 Jun 14, 2023	SELL	$1.27 - $2.26 $626 - $1,114	-493 Reduced 7.24%	6,314 $9.6 Million
Q4 2022 Mar 30, 2023	BUY	$1.27 - $2.26 $205 - $366	162 Added 2.63%	6,314 $9,000
Q4 2022 Feb 15, 2023	BUY	$1.27 - $2.26 $205 - $366	162 Added 2.63%	6,314 $9,000
Q3 2022 Jun 14, 2023	SELL	$1.41 - $2.79 $923 - $1,827	-655 Reduced 9.62%	6,152 $13 Million
Q3 2022 Mar 30, 2023	SELL	$1.41 - $2.79 $13,028 - $25,779	-9,240 Reduced 60.03%	6,152 $13,000
Q3 2022 Nov 14, 2022	BUY	$1.41 - $2.79 $8,674 - $17,164	6,152 New	6,152 $13,000
Q1 2022 May 12, 2022	SELL	$1.91 - $3.98 $29,398 - $61,260	-15,392 Closed	0 $0
Q4 2021 Jun 21, 2023	BUY	$3.53 - $5.5 $30,305 - $47,217	8,585 Added 126.12%	15,392 $57,000
Q4 2021 Mar 30, 2023	SELL	$3.53 - $5.5 $5,955 - $9,278	-1,687 Reduced 9.88%	15,392 $57,000
Q4 2021 Feb 15, 2022	SELL	$3.53 - $5.5 $5,955 - $9,278	-1,687 Reduced 9.88%	15,392 $57,000
Q3 2021 Jun 21, 2023	BUY	$4.99 - $6.55 $51,257 - $67,281	10,272 Added 150.9%	17,079 $85,000
Q3 2021 Mar 30, 2023	SELL	$4.99 - $6.55 $41,007 - $53,827	-8,218 Reduced 32.49%	17,079 $85,000
Q3 2021 Nov 15, 2021	SELL	$4.99 - $6.55 $41,007 - $53,827	-8,218 Reduced 32.49%	17,079 $85,000
Q2 2021 Jun 21, 2023	BUY	$6.24 - $8.22 $115,377 - $151,987	18,490 Added 271.63%	25,297 $164,000
Q2 2021 Mar 30, 2023	BUY	$6.24 - $8.22 $33,558 - $44,207	5,378 Added 27.0%	25,297 $164,000
Q2 2021 Aug 16, 2021	BUY	$6.24 - $8.22 $157,728 - $207,776	25,277 Added 126385.0%	25,297 $165,000
Q1 2021 Jun 26, 2023	BUY	$6.74 - $10.95 $88,374 - $143,576	13,112 Added 192.63%	19,919 $137 Million
Q1 2021 Mar 30, 2023	BUY	$6.74 - $10.95 $7,804 - $12,680	1,158 Added 6.17%	19,919 $137,000
Q1 2021 May 14, 2021	SELL	$6.74 - $10.95 $126,314 - $205,213	-18,741 Reduced 99.89%	20 $137,000
Q4 2020 Jun 22, 2023	BUY	$3.75 - $10.56 $44,827 - $126,234	11,954 Added 175.61%	18,761 $191,000
Q4 2020 Mar 30, 2023	SELL	$3.75 - $10.56 $2,152 - $6,061	-574 Reduced 2.97%	18,761 $191,000
Q4 2020 Feb 16, 2021	SELL	$3.75 - $10.56 $2,152 - $6,061	-574 Reduced 2.97%	18,761 $191,000
Q3 2020 Jun 26, 2023	BUY	$3.5 - $6.2 $43,848 - $77,673	12,528 Added 184.05%	19,335 $67,000
Q3 2020 Mar 30, 2023	SELL	$3.5 - $6.2 $20,062 - $35,538	-5,732 Reduced 22.87%	19,335 $67,000
Q3 2020 Nov 13, 2020	SELL	$3.5 - $6.2 $20,062 - $35,538	-5,732 Reduced 22.87%	19,335 $68,000
Q2 2020 Jun 26, 2023	BUY	$2.16 - $5.46 $39,441 - $99,699	18,260 Added 268.25%	25,067 $125,000
Q2 2020 Mar 30, 2023	SELL	$2.16 - $5.46 $1,587 - $4,013	-735 Reduced 2.85%	25,067 $125,000
Q2 2020 Aug 14, 2020	SELL	$2.16 - $5.46 $1,587 - $4,013	-735 Reduced 2.85%	25,067 $125,000
Q1 2020 Jul 12, 2023	BUY	$1.46 - $7.19 $27,732 - $136,574	18,995 Added 279.05%	25,802 $87,000
Q1 2020 Mar 30, 2023	BUY	$1.46 - $7.19 $28,452 - $140,118	19,488 Added 308.65%	25,802 $87,000
Q1 2020 May 15, 2020	BUY	$1.46 - $7.19 $37,670 - $185,516	25,802 New	25,802 $88,000

Others Institutions Holding PGEN

# of Institutions

148

Shares Held

162M

Call Options Held

150K

Put Options Held

29.5K

Third Security, LLC

83.5M
Shares

$164 Million
73.5% of portfolio
Patient Capital Management, LLC Baltimore, MD

17.9M
Shares

$35 Million
1.03% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

10.9M
Shares

$21.3 Million
0.02% of portfolio
Black Rock Inc. New York, NY

10.2M
Shares

$20.1 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

8.33M
Shares

$16.3 Million
0.0% of portfolio

View Full List

About PRECIGEN, INC.

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $408M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

More about PGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account